Nausea, diarrhea, vomiting, constipation, reflux, and reduced appetite are most common
The intended therapeutic effect is the same, but the manufacturing process and regulatory oversight differ significantly
GLP-1 receptor agonists enhance regulatory T cell function
GLP-1s like Ozempic and Wegovy also impact gastric emptying by allowing food to stay in your stomach (and make you feel full) longer
That leads to a cycle of symptoms going up and down rather than gradually improving over time. Thats why doctors recommend increasing the dosage gradually, which allows your body to get used to the medication while keeping weight loss on track
positive-positive or negative-negative), two samples with negative expression in the primary sites showed positive-GLP-1R expression in the metastatic sites